diethylstilbestrol des also known stilbestrol stilboestrol nonsteroidal estrogen medication presently rarely past widely used variety indications including pregnancy support history recurrent miscarriage hormone therapy menopausal symptoms estrogen deficiency treatment prostate cancer breast cancer used treatment prostate cancer breast hoover colleagues reported adverse health outcomes linked des including infertility miscarriage ectopic pregnancy preeclampsia preterm birth stillbirth infant death menopause prior age breast cancer cervical cancer vaginal commonly taken mouth des available use routes well instance vaginal topical injection des estrogen agonist estrogen receptors biological target estrogens like synthetic nonsteroidal estrogen stilbestrol group differs natural estrogen estradiol various compared estradiol des greatly improved bioavailability taken mouth resistant metabolism shows relatively increased effects certain parts body like liver differences result des increased risk blood clots cardiovascular issues certain adverse des discovered introduced medical use medication given pregnant women incorrect belief would reduce risk pregnancy complications des shown cause clearcell carcinoma rare vaginal tumor exposed medication united states food drug administration subsequently withdrew approval des treatment pregnant followup studies indicated des also potential cause variety significant adverse medical complications lifetimes exposed including xy genital united states national cancer institute children born mothers took des undergo special medical exams regular basis screen complications result medication individuals exposed des mothers pregnancies commonly referred des daughters des since discovery toxic effects des largely discontinued mostly longer des used past following citations needed des used dosage mgday menopausal hormone interest use des treat prostate cancer continues however use bioidentical parenteral estrogens like polyestradiol phosphate advocated favor oral synthetic estrogens like des due much lower risk cardiovascular addition prostate cancer interest use des treat breast cancer continues today however similarly case prostate cancer arguments use bioidentical estrogens like estradiol instead des breast oral des mgday effective treatment hot flashes men undergoing androgen deprivation therapy prostate although des used support pregnancy later found effective use actually mgday des associated high rates side effects including nausea vomiting abdominal discomfort headache bloating incidence pigmentation breast areolae often dark almost black des pigmentation occurs synthetic estrogens des much greater natural estrogens mechanism difference progestogens like hydroxyprogesterone caproate reported reduce nipple hyperpigmentation induced highdose estrogen men treated prostate cancer des found produce high rates gynecomastia breast development studies des form highdose estrogen therapy prostate cancer associated considerable cardiovascular morbidity risk dosage mgday des associated increase noncancerrelated mostly cardiovascular addition incidence venous mgday dosage des associated incidence thromboembolism incidence cardiovascular complications lower dosage mgday des associated rate death due cardiovascular events relative orchiectomy des linked variety longterm adverse effects women treated pregnancy andor offspring including increased risk comprehensive animal study found plethora adverse effects des limited rodent studies reveal female reproductive tract cancers abnormalities reaching generation evidence adverse effects irregular menstrual cycles intersexual grandchildren des additionally evidence also points transgenerational effects sons time however extent des transgenerational effects humans fully understoodcitation needed des assessed past clinical studies extremely high doses much des estrogen specifically highly potent full agonist estrogen receptors approximately affinity estradiol erα erβ however values nm nm des erα erβ respectively reported suggesting spite binding affinity two receptors severalfold preference activation erβ addition nuclear ers des agonist g proteincoupled estrogen receptor gper albeit relatively low affinity des produces biological effects attributed natural estrogens like includes effects uterus vagina mammary glands pituitary gland dosage mgday des approximately equivalent dosage µgday ethinylestradiol terms systemic estrogenic similarly ethinylestradiol des shows marked disproportionately strong effect liver protein whereas systemic estrogenic potency estropipate piperazine estrone sulfate similar potency micronized estradiol hepatic estrogenic potency des estropipate stronger potency dosage equivalent systemic estrogenic des least three mechanisms action treatment prostate suppresses gonadal androgen production hence circulating androgen levels due antigonadotropic effects stimulates hepatic sex hormonebinding globulin shbg production thereby increasing circulating levels shbg decreasing free fraction testosterone dihydrotestosterone dht circulation may direct cytotoxic effects testes prostate des also found decrease dna synthesis high des longacting estrogen nuclear retention around due estrogenic activity des antigonadotropic exerts negative feedback axis hpg axis suppresses secretion gonadotropins luteinizing hormone lh folliclestimulating hormone fsh suppresses sex hormone production well gamete production maturation study ovulation inhibition found mgday oral des effective ovulation occurring single des consistently suppresses testosterone levels men castrate range however also reported mgday des results approximately suppression testosterone levels albeit wide interindividual said doses des less mgday effect testosterone however addition extremely low dosage mgday des cyproterone acetate found result synergistic antigonadotropic effect suppress testosterone levels castrate range des mgday similar testosterone suppression dose mgday suggesting suppression testosterone levels maximal addition ers vitro study found des also possesses activity albeit relatively weak variety steroid hormone whereas study found values nm nm des erα erβ respectively medication showed significant glucocorticoid activity concentration μm surpassed nm dexamethasone well significant antagonism androgen progesterone mineralocorticoid receptors inhibition positive control stimulation respectively concentration also showed approximately inhibition activation pparγ lxrα concentration researchers stated best knowledge first report actions des hypothesized actions could involved clinical effects des instance prostate cancer notably particularly high dosages des however also noted importance activities requires study animal models pharmacologically relevant des identified antagonist three isotypes estrogenrelated receptors errs errα errβ halfmaximal inhibition occurs concentration des wellabsorbed oral oral dosage mgday des plasma levels des hours following last dose ranged ngml sublingual administration des appears estrogenic potency oral des intrauterine des studied treatment uterine oral des thought clinical estrogenic potency des distribution halflife des affinity shbg corticosteroidbinding globulin hence bound proteins plasma protein binding des greater hydroxylation aromatic rings des subsequent conjugation ethyl side chains accounts des metabolism oxidation accounts remaining dominated conjugation conjugation des consists glucuronidation oxidation includes dehydrogenation medication also known produce paroxypropione des produces transient quinonelike reactive intermediates cause cellular genetic damage may help explain known carcinogenic effects des however research indicates toxic effects des may simply due overactivation contrast estradiol hydroxyl groups des undergo oxidation estronelike elimination halflife des metabolites des excreted urine des belongs stilbestrol group nonsteroidal openring analogue steroidal estrogen des prepared anethole also happens weakly anethole demethylated form anol anol spontaneously dimerized dianol hexestrol des subsequently synthesized via structural modification shown xray crystallography molecular dimensions des almost identical estradiol particularly regards distance terminal hydroxyl des first synthesized early leon golberg graduate student sir robert robinson dyson perrins laboratory university oxford golbergs research based work wilfrid lawson courtauld institute biochemistry led sir edward charles dodds middlesex hospital medical school part university college london report synthesis published nature february des research funded uk medical research council mrc policy patenting drugs discovered using public funds patented des produced pharmaceutical chemical companies worldwidecitation needed des first marketed medical use approved united states food drug administration fda september tablets mg four indications gonorrheal vaginitis atrophic vaginitis menopausal symptoms postpartum lactation suppression prevent breast gonorrheal vaginitis indication dropped antibiotic penicillin became available inception drug highly charles huggins clarence hodges university chicago found estradiol benzoate des first effective drugs treatment metastatic prostate des first cancer orchiectomy des standard initial treatment symptomatic advanced prostate cancer years gnrh agonist leuprorelin found efficacy similar des without estrogenic effects approved late des fdaapproved estrogen replacement therapy estrogen deficiency states ovarian dysgenesis premature ovarian failure oophorectomycitation needed des used offlabel prevent adverse pregnancy outcomes women history miscarriage july fda approved use des indication first approval granted bristolmyers squibb allowing use mg later mg tablets des pregnancy approvals granted pharmaceutical companies later recommended regimen started mg per day seventh eighth weeks pregnancy first day last menstrual period increased every week mg per day week increased every week mg per day mg per day week mg per day week des originally considered effective safe pregnant woman developing baby aggressively marketed routinely prescribed sales peaked early doubleblind clinical trial university chicago assessed pregnancy outcomes women assigned either receive receive study showed benefit taking des pregnancy adverse pregnancy outcomes reduced women given des late six seven leading textbooks obstetrics said des ineffective preventing despite absence evidence supporting use des prevent adverse pregnancy outcomes des continued given pregnant women report published new england journal medicine showed probable link des vaginal clear cell adenocarcinoma girls young women exposed drug utero later year fda sent fda drug bulletin us physicians advising use des pregnant women fda also removed prevention miscarriage indication des use added pregnancy contraindication des february fda ordered mg mg tablets des withdrawn effective february number persons exposed des pregnancy utero period unknown may high million united states des also used countries notably france netherlands great britain beginning des prescribed prepubescent girls begin puberty thus stop growth closing growth plates bones despite clear link cancer doctors continued recommend hormone excess des found effective androgens treatment advanced breast cancer postmenopausal des hormonal treatment choice advanced breast cancer postmenopausal women fda approved tamoxifen selective estrogen receptor modulator efficacy similar des fewer side several sources medical literature indicate des used component hormone therapy transgender attempt restrict offlabel use des postcoital contraceptive become prevalent many university health services following publication influential study jama emergency situations rape fda drug bulletin sent us physicians pharmacists said fda approved restricted conditions postcoital contraceptive use fda said actually given never give approval manufacturer market des postcoital contraceptive would approve indication emergency situations rape incest manufacturer provided patient labeling special packaging set fda final rule published discourage offlabel use des postcoital contraceptive fda removed des mg tablets market ordered labeling lower doses mg lower des still approved indications changed state drug product used postcoital contraceptive block capital letters first line physician prescribing information package insert prominent conspicuous location container carton offlabel use yuzpe regimen certain regular combined oral contraceptive pills superseded offlabel use des postcoital fda removed postpartum lactation suppression prevent breast engorgement approved indications des approved indications des treatment advanced prostate cancer treatment advanced breast cancer postmenopausal women last remaining us manufacturer des eli lilly stopped making marketing needed diethylstilbestrol used countless times studies rats discovered des causing vaginal cancer experiments began male female many male rats injected des male rats injected olive oil considered control group received dosage days researchers performed light microscopy electron microscopy confocal laser microscopy electron confocal laser microscopy prevalent sertoli cells somatic cells spermatids develop testes formed days later rats injected diethylstilbestrol compared rats control proceeding completion trial understood rats older age injected des experienced delay sertoli cell maturation underdeveloped epididymides drastic decrease weight compared female rats used inbred given des combined food rats divided three groups one group received diethylstilbestrol one group des mixed diet third group des administered diet day rats given des unfortunately died delivering group received des food days pregnant resulted early abortion delivery outcomes showed des detrimental effect pregnancy administered often providing dosing diethylstilbestrol later pregnancy term also made visible occurrence abortions among overall interaction des female rats concluded rats experiencing abortions improper fetal growth increase review people treated exposed des done find longterm effects would people long time treated pregnancy des known toxic adverse effects hormone therapy exposure des associated increased risk breast cancer des mothers relative risk lifetime risk clearcell cervicovaginal cancer des daughters side effects des proving longterm cause increased risks cancer continued work see far adverse effects des go previous therapy affect offspring mothers ability test safety des animals first obtained fda results preliminary tests showed des harmed reproductive systems animals application results humans could determined fda could act regulatory new drug applications des approval withdrawn decision made fda based scientific uncertainty however decision resulted significant political pressure fda came compromise compromise meant des would available prescription would warnings effects bottle warning dropped des finally gained fda approval prescription pregnant women diabetes method preventing miscarriages led widespread prescription des pregnant fda recommended prescription des pregnant result des began see withdraw us market starting european market starting fda still withdraw approval use des des classified group carcinogen international agency research cancer classification carcinogen des fda approval withdrawn des currently use veterinary practices research trials allowed medical ethics regard approval use diethylstilbestrol dismissed actions fda pharmaceutical companies making des time use vice president american drug manufacturers association carson frailey employed drug companies creating des order help get approved food drug administration fda nancy langston author retreat precaution regulating diethylstilbestrol des endocrine disruptors environmental health states frailey persuaded fiftyfour doctors around country write fda describing clinical experiences total five thousand patients four fiftyfour doctors felt des approved result concerns many fda medical staff fdas drug chief theodore klumpp recommended fda approve excerpt describes des unethically approved shows motivation behind approval benefit drug companies rather people going use drug approval des violates values medical ethics autonomy nonmaleficence beneficence justice little thought put des would affect decisions made fda leaders approve des without study convince doctors dissimulate opinions use des unethical des approved public consumption warnings des made available separate circular patients would see doctors could get warning circular writing drug companies requesting letters companies fda regulators reveal groups feared woman ever saw many potential risks des might present might refuse take else might sue company prescribing doctors get cancer liver damage taking women informed possible effects des doctors fda regulators afraid des would fail never approved costing drug companies millions dollars act distributing potentially dangerous medicine patients regardless effect harm may solely monetary gain unethicalcitation needed negative publicity surrounding discovery dess longterm effects resulted huge wave lawsuits united states manufacturers culminated landmark decision supreme court california sindell v abbott laboratories court imposed rebuttable presumption market share liability upon des manufacturers proportional share market time drug consumed mother particular plaintiffcitation needed eli lilly pharmaceutical company manufacturing des university chicago action filed regard clinical trials three women filed claim daughters developments abnormal cervical cellular formations well reproductive abnormalities plaintiffs asked courts certify case class action declined courts however courts issued opinion case merit court held eli lilly duty notify risks des became aware become aware illinois tort law plaintiffs recover theories breach duty warn strict liability plaintiffs must alleged injury ultimately claims breach duty warn strict liability due plaintiffs citing risk physical injury others physical injury case dismissed although case certified class action claims breach duty warn strict liability dismissed courts dismiss battery issue determine whether university chicago committed battery women case settled part settlement agreement case mink v university chicago attorneys plaintiffs negotiated university provide free medical exams offspring exposed des utero experiments well treat daughters women involved develop desassociated vaginal cervical february thousand pending legal actions des companies manufactured des according formula largest barrier recovery determining manufacturer supplied drug particular many successful cases relied joint several parties holding liability lawsuit filed boston federal court des daughters say breast cancers result des prescribed mothers pregnant cases survived daubert hearing fecho sisters initiated breast cancerdes link litigation agreed undisclosed settlement amount second day trial remaining litigants received various advocacy group des action usa helped provide information support desexposed persons engaged alan turing groundbreaking cryptographer founder computing science programmable computers also proposed actual theoretical model biological morphogenesis forced onto medication induce chemical castration punitive discredited treatment homosexual behaviour shortly died ambiguous least one occasion new zealand early diethylstilbestrol prescribed treatment james herriot describes case regarding treating small dogs testicular sertoli cell tumor book things bright beautiful herriot decided prescribe high dose new drug stilboestrol recurring tumor amusing side effect male dog became attractive male dogs followed terrier around village weeks herriot comments story knew new drug said feminising effect surely extent des successful treating female canine incontinence stemming poor sphincter control still available compounding pharmacies low mg dose carcinogenic properties problematic generally administered day seven ten days every week neededcitation needed greatest usage des livestock industry used improve feed conversion beef poultry des used growth hormone beef poultry industries later found cause cancer phased although des discovered harmful humans veterinary use immediately halted des still used growth promoter terrestrial livestock fish parts world including httpsenwikipediaorgwikidiethylstilbestrol